June 19, 2015
KANSAS CITY, Kan.— This Sunday, June 21st, is not only Father’s Day, it’s Prostate Cancer Awareness Day in Kansas City. The University of Kansas Hospital is teaming with The Kansas City Royals to bring that message to dads and their families during the game at Kauffman Stadium at 1:10 p.m. against the Boston Red Sox.
Prostate cancer affects as many men as breast cancer affects women each year. About 40% of men who survive prostate cancer will see a recurrence of cancer. That’s why a new test perfected by a doctor at The University of Kansas Hospital offers so much hope. Reginald Dusing, M.D., says the radioactive compound helps pinpoint the cancer three times better than traditional methods, and is saving lives.
“We have many patients who have been diagnosed, been treated and gone back into remission,” said Dusing. “It’s pretty exciting and I think it will change the way that recurrent prostate cancer is treated.”
In the video below, Dr. Dusing explains why the compound used to detect most cancers won’t work with prostate cancer, how testing proved the new compound works three times better and how it will change the way prostate cancer is treated. Also, a prostate cancer patient, Stuart May talks about how this new test helped him and helped his doctors come up with a treatment plan.
Video interview with Reg Dusing, M.D., radiologist.
Prostate cancer is called a silent killer. It’s the second leading cause of cancer death in U.S. men and often has no symptoms until it has advanced or spread to other areas of the body. Yet when found early, prostate cancer is curable for up to 90 percent of patients.
Brantley Thrasher, M.D., a urologist at The University of Kansas Hospital talks about the warning signs, the risk factors and ways to reduce your chances of developing prostate cancer.
Video interviews with Dr. Thrasher, Dr. Jeffrey Holzbeierlein and registered dietician Sarah Camey.